- Home
- CTKB vs CCIX Comparison
CTKB vs CCIX Comparison
Compare CTKB & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTKB
- CCIX
- Stock Information
- Founded
- CTKB 1990
- CCIX 2023
- Country
- CTKB United States
- CCIX United States
- Employees
- CTKB N/A
- CCIX N/A
- Industry
- CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CCIX
- Sector
- CTKB Health Care
- CCIX
- Exchange
- CTKB Nasdaq
- CCIX Nasdaq
- Market Cap
- CTKB 433.8M
- CCIX 393.4M
- IPO Year
- CTKB 2021
- CCIX 2024
- Fundamental
- Price
- CTKB $4.01
- CCIX $10.75
- Analyst Decision
- CTKB Hold
- CCIX
- Analyst Count
- CTKB 4
- CCIX 0
- Target Price
- CTKB $6.00
- CCIX N/A
- AVG Volume (30 Days)
- CTKB 691.9K
- CCIX 170.7K
- Earning Date
- CTKB 11-05-2025
- CCIX 01-01-0001
- Dividend Yield
- CTKB N/A
- CCIX N/A
- EPS Growth
- CTKB N/A
- CCIX N/A
- EPS
- CTKB N/A
- CCIX 0.28
- Revenue
- CTKB $196,035,000.00
- CCIX N/A
- Revenue This Year
- CTKB N/A
- CCIX N/A
- Revenue Next Year
- CTKB $7.25
- CCIX N/A
- P/E Ratio
- CTKB N/A
- CCIX $37.95
- Revenue Growth
- CTKB N/A
- CCIX N/A
- 52 Week Low
- CTKB $2.37
- CCIX $10.04
- 52 Week High
- CTKB $7.63
- CCIX $11.66
- Technical
- Relative Strength Index (RSI)
- CTKB 51.16
- CCIX 55.31
- Support Level
- CTKB $4.00
- CCIX $10.73
- Resistance Level
- CTKB $4.42
- CCIX $11.32
- Average True Range (ATR)
- CTKB 0.20
- CCIX 0.14
- MACD
- CTKB 0.01
- CCIX -0.01
- Stochastic Oscillator
- CTKB 38.81
- CCIX 12.31
About CTKB Cytek Biosciences Inc.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
About CCIX Churchill Capital Corp IX Ordinary Shares
Churchill Capital Corp IX is a blank check company.